San Diego Union Tribune - January 22, 2004
Irish drugmaker Elan Corp. said it sold its San Diego office property, which it will lease back from the new owner, which it wouldn't disclose. Elan, which has its North American biopharmaceutical headquarters in San Diego, said it raised a collective $45 million from the sale of the two-building San Diego campus, as well as the sale of manufacturing businesses in Switzerland and Italy.
The sale of the two office buildings will not affect its employees or day-to-day operations.
Sphere: Related Content
Tuesday, January 27, 2004
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment